Compare Enveric Biosciences Inc (ENVB) vs NetApp Inc. (NTAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs NetApp Inc. — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while NetApp Inc. trades at $160.06 (market cap $31.76B). The key difference: NetApp Inc. is far larger — about 5969.9× Enveric Biosciences Inc's market cap, and NetApp Inc. pays a 1.28% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | NTAP | |
|---|---|---|
Market Cap | $5.32M | $31.76B |
Sector | Health | Technology |
52-Week High | $17.40 | $181.08 |
52-Week Low | $1.28 | $94.11 |
Enterprise Value | $408.82K | $30.91B |
Dividend Yield | — | 1.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NetApp (NTAP) trades at $174.58, up 6.5% over the past 24 hours, reflecting strong momentum. The stock exhibits bullish technical signals with moving averages supporting an uptrend, though RSI levels suggest potential overbought conditions. Fundamentally, the company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $2.43 exceeding the $2.27 estimate. Revenue for 2025 reached $6.57 billion, with a net income margin of 18.43% and a high return on equity of 106.73%. Recent news highlights NetApp's strategic focus on AI infrastructure and a dividend payment scheduled for July 2026.
The outlook for NTAP is positive, driven by enterprise AI demand and consistent earnings performance. Investment opportunities include exposure to data storage growth and strong profitability metrics. Key risks involve high valuation multiples, competitive pressures in the tech sector, and sensitivity to macroeconomic trends affecting IT spending. Analyst consensus is mixed, with a price target of $167.45 below the current price, indicating caution despite overall bullish sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About NetApp Inc.
NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →
